Metraipolis › archive › dc_cf0804a64ee8

Growth Outcomes and Relapse Risk in Pediatric Medulloblastoma Survivors with and Without Growth Hormone Therapy: A 23-Year Single-Center Cohort Study — Europe PMC PMID:42123204

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42123204
DOI: 10.3390/jcm15093472
License (as archived): solo-consultazione
Archived: 2026-11-02T22:10:22.708Z
SHA-256 of the archived text: 459460121f9886267cb71f2e3ef84f2ad0ca5be62d50679e0f4aee659b4c0dc0
Stable URL of this page: https://metraipolis.com/documento/dc_cf0804a64ee8

How to cite

Growth Outcomes and Relapse Risk in Pediatric Medulloblastoma Survivors with and Without Growth Hormone Therapy: A 23-Year Single-Center Cohort Study — Europe PMC PMID:42123204 — Europe PMC (en), https://europepmc.org/article/MED/42123204 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf0804a64ee8 (Metraipolis archive dc_cf0804a64ee8, sha256 459460121f9886267cb71f2e3ef84f2ad0ca5be62d50679e0f4aee659b4c0dc0)

BibTeX

@misc{dccf0804a64ee8,
  title = {Growth Outcomes and Relapse Risk in Pediatric Medulloblastoma Survivors with and Without Growth Hormone Therapy: A 23-Year Single-Center Cohort Study — Europe PMC PMID:42123204},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42123204},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf0804a64ee8; sha256 459460121f9886267cb71f2e3ef84f2ad0ca5be62d50679e0f4aee659b4c0dc0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123204. Agents can read the archived copy with the MCP tool read_document.